Company news
Establishment Labs Holdings Inc. (NASDAQ:ESTA) news
Every Establishment Labs Holdings Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6
July 23, 2026
Establishment Labs® Appoints Taylor Harris to Board of Directors
June 29, 2026
Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index
June 25, 2026
Establishment Labs Reports First Quarter 2026 Financial Results
May 6, 2026
Establishment Labs® Refinances Credit Facility
April 30, 2026
Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6
April 23, 2026
Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market
April 7, 2026
Establishment Labs Announces Leadership Transition to Support Next Phase of Growth
February 24, 2026
Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
February 24, 2026
Establishment Labs to Present at TD Cowen's 46th Annual Health Care Conference
February 18, 2026
Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24
February 10, 2026
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
January 12, 2026
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
December 31, 2025
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
December 29, 2025
Establishment Labs to Present at Jefferies London Healthcare Conference
November 7, 2025
Establishment Labs Reports Third Quarter 2025 Financial Results
November 5, 2025
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5
October 22, 2025
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal
October 14, 2025
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
October 9, 2025
Establishment Labs Reports Second Quarter 2025 Financial Results
August 7, 2025
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7
July 25, 2025
Establishment Labs Hosting Investor Day on June 12
June 11, 2025
Establishment Labs to Present at Jefferies Global Healthcare Conference
June 3, 2025
Establishment Labs Appoints Peter Caldini as Chief Executive Officer
May 7, 2025
Establishment Labs Reports First Quarter 2025 Financial Results
May 7, 2025
Establishment Labs to Announce First Quarter 2025 Financial Results on May 7
April 24, 2025
Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12
April 10, 2025
Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025
March 20, 2025
Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®
March 6, 2025
Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance
February 26, 2025
Establishment Labs to Present at TD Cowen's 45th Annual Health Care Conference
February 25, 2025
Establishment Labs to Present at Citi’s 2025 Unplugged Medtech and Life Sciences Access Day
February 21, 2025
Establishment Labs Launches Preservé™
February 18, 2025
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26
February 14, 2025
Establishment Labs Announces CEO Transition
January 13, 2025
Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
Establishment Labs Announces Participation in Upcoming Investment Conferences
November 11, 2024
Establishment Labs Reports Third Quarter 2024 Financial Results
November 7, 2024
Establishment Labs Announces $50 Million Registered Direct Offering
November 7, 2024
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
October 31, 2024
Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7
October 24, 2024
Establishment Labs Publishes 2024 Post Market Surveillance Report
October 15, 2024
First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants
October 2, 2024
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
September 26, 2024
Establishment Labs Reports Second Quarter 2024 Financial Results
August 6, 2024
Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6
July 24, 2024
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
May 23, 2024
Establishment Labs Reports First Quarter 2024 Financial Results
May 8, 2024
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
May 2, 2024
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
May 1, 2024